Search Results - "FRANCOIS, Géraldine"
-
1
Assist-control ventilation vs. low levels of pressure support ventilation on sleep quality in intubated ICU patients
Published in Intensive care medicine (01-07-2007)“…To compare the impact of assist-control ventilation (ACV) and pressure support ventilation with 6 cmH2O inspiratory pressure (low PSV) on sleep quality…”
Get full text
Journal Article -
2
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
Published in The lancet respiratory medicine (01-07-2020)“…Lung cancer screening with low-dose chest CT (LDCT) reduces the mortality of eligible individuals. Blood signatures might act as a standalone screening tool,…”
Get full text
Journal Article -
3
Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors
Published in Targeted oncology (01-08-2018)“…Background The prognosis of patients with non-small cell lung cancer (NSCLC) who develop leptomeningeal metastasis (LM) is poor. Objective To assess the…”
Get full text
Journal Article -
4
Respiratory-gated 18F-FDG PET imaging in lung cancer: effects on sensitivity and specificity
Published in Acta radiologica (1987) (01-07-2011)“…Respiratory motion is known to deteriorate positron emission tomography (PET) images and may lead to potential diagnostic errors when a standardized uptake…”
Get more information
Journal Article -
5
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study
Published in The lancet respiratory medicine (29-10-2024)“…Combined treatment with anti-PD-1 and anti-CTLA-4 antibodies has shown superiority over chemotherapy in patients with advanced non-small-cell lung cancer…”
Get full text
Journal Article -
6
A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA–B GFPC 04-2020Study)
Published in Lung cancer (Amsterdam, Netherlands) (01-08-2024)“…•Stage-III-N2 non-small-cell lung cancer (NSCLC) management remains challenging.•The consistency of Tumor Board meeting (TBM) decisions was assessed.•None of…”
Get full text
Journal Article -
7
Physiologic Determinants of Exercise Capacity in Pulmonary Langerhans Cell Histiocytosis: A Multidimensional Analysis
Published in PloS one (10-01-2017)“…Reduced exercise capacity severely impacts quality of life in pulmonary Langerhans cell histiocytosis. Ascertaining mechanisms that impair exercise capacity is…”
Get full text
Journal Article -
8
Detection of Pulmonary Nodules on Ultra-low Dose Chest Computed Tomography With Deep-learning Image Reconstruction Algorithm
Published in Journal of thoracic imaging (13-09-2024)“…To evaluate the accuracy of ultra-low dose (ULD) chest computed tomography (CT), with a radiation exposure equivalent to a 2-view chest x-ray, for pulmonary…”
Get full text
Journal Article -
9
Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small-Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study)
Published in OncoTargets and therapy (01-01-2020)“…Few data have been published on the clinical and histopathological characteristics of advanced non-small-cell lung cancer (NSCLC) patients with high PD-L1…”
Get full text
Journal Article -
10
Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study
Published in The European respiratory journal (01-12-2017)“…Severe emphysema is a difficult to treat condition with limited efficacy of currently available treatments. Endobronchial coil treatment (ECT) is a minimally…”
Get full text
Journal Article -
11
PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 “EPNEC” study
Published in Therapeutic advances in medical oncology (2020)“…Background: Few data are available on programmed cell-death-protein-1–ligand-1 (PD-L1) expression on large-cell neuroendocrine carcinomas of the lung (LCNECs)…”
Get full text
Journal Article -
12
Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)
Published in Respiratory research (09-05-2018)“…The REVOLENS study compared lung volume reduction coil treatment to usual care in patients with severe emphysema at 1 year, resulting in improved…”
Get full text
Journal Article -
13
Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small-Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study)
Published in OncoTargets and therapy (01-01-2020)“…BACKGROUNDFew data have been published on the clinical and histopathological characteristics of advanced non-small-cell lung cancer (NSCLC) patients with high…”
Get full text
Report